|
Volumn 38, Issue 4 SUPPL. 11, 2001, Pages 4-11
|
Fundamentals of the psoralen-based helinxTM technology for inactivation of infectious pathogens and leukocytes in platelets and plasma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOTOSALEN;
NUCLEIC ACID;
PSORALEN DERIVATIVE;
THROMBOCYTE CONCENTRATE;
UNCLASSIFIED DRUG;
BLOOD BANK;
BLOOD TRANSFUSION;
CONTAMINATION;
CROSS LINKING;
DRUG STRUCTURE;
GENOME;
HEPATITIS B VIRUS;
ILLUMINATION;
LEUKOCYTE;
LIGHT;
MEDICAL TECHNOLOGY;
PHOTOCHEMISTRY;
PLASMA TRANSFUSION;
PRIORITY JOURNAL;
REACTION ANALYSIS;
REVIEW;
THROMBOCYTE TRANSFUSION;
ULTRAVIOLET A RADIATION;
VIRUS INACTIVATION;
|
EID: 0035191824
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: 10.1016/S0037-1963(01)90118-0 Document Type: Article |
Times cited : (120)
|
References (50)
|